Cas:337956-06-6 Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester manufacturer & supplier

We serve Chemical Name:Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester CAS:337956-06-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester

Chemical Name:Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester
CAS.NO:337956-06-6
Synonyms:Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester;Methyl 1-amino-2-indanecarboxylate;1H-Indene-2-carboxylic acid, 1-amino-2,3-dihydro-, methyl ester
Molecular Formula:C11H13NO2
Molecular Weight:191.226
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:290.4±40.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.560
PSA:52.32000
Exact Mass:191.094635
LogP:1.24

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indene-2-carboxylic acid, 1-amino-2,3-dihydro-, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester Use and application,Methyl 1-amino-2-indanecarboxylate technical grade,usp/ep/jp grade.


Related News: The booster campaign, with shots administered by health maintenance organisations, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA). (S)-1-(4-bromoacetamidobenzyl)EDTA manufacturers RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO 4-[2-(2-aminopyridin-6-yl)ethyl]benzoic acid suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. 2-(1,2-dimethyl-5-((4-(trifluoromethyl)phenyl)sulfonyl)-1H-indol-3-yl)ethan-1-amine vendor & factory.